Literature DB >> 23136200

Nonalloreactive T cells prevent donor lymphocyte infusion-induced graft-versus-host disease by controlling microbial stimuli.

Hao Wei Li1, Jessica Sachs, Clarimel Pichardo, Roderick Bronson, Guiling Zhao, Megan Sykes.   

Abstract

In mice, graft-versus-host reactions, associated with powerful graft-versus-tumor effects, can be achieved without graft-versus-host disease (GVHD) by delayed administration of donor lymphocyte infusions (DLI) to established mixed chimeras. However, GVHD sometimes occurs after DLI in established mixed chimeric patients. In contrast to mice, in which T cell recovery from the thymus occurs prior to DLI administration, human T cell reconstitution following T cell-depleted hematopoietic cell transplantation is slow, resulting in lymphopenia at the time of DLI. We demonstrate in this study that T cell lymphopenia is an independent risk factor for GVHD following DLI in the absence of known inflammatory stimuli. DLI-induced GVHD was prevented in lymphopenic recipients by prior administration of a small number of nonalloreactive polyclonal T cells, insufficient to prevent lymphopenia-associated expansion of subsequently administered T cells, through a regulatory T cell-independent mechanism. GVHD was not inhibited by T cells with irrelevant specificity. Moreover, administration of antibiotics reduced the severity of GVHD in lymphopenic hosts. Accumulation of DLI-derived effector T cells and host hematopoietic cell elimination were markedly diminished by regulatory T cell-depleted, nonalloreactive T cells. Finally, thymectomized mixed chimeras showed increased GVHD following delayed DLI. Collectively, our data demonstrate that in the absence of known conditioning-induced inflammatory stimuli, T cell lymphopenia is a risk factor for GVHD in mixed chimeras receiving delayed DLI. Our data suggest that the predisposition to GVHD can at least in part be explained by the presence of occult inflammatory stimuli due to the absence of T cells to control microbial infections.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23136200      PMCID: PMC3524834          DOI: 10.4049/jimmunol.1200045

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  74 in total

Review 1.  Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy.

Authors:  Christopher A Klebanoff; Hung T Khong; Paul A Antony; Douglas C Palmer; Nicholas P Restifo
Journal:  Trends Immunol       Date:  2005-02       Impact factor: 16.687

2.  Recent immune status determines the source of antigens that drive homeostatic T cell expansion.

Authors:  William C Kieper; Amy Troy; J Theodore Burghardt; Chris Ramsey; Joon Youb Lee; Han-Qing Jiang; Wolfgang Dummer; Hao Shen; John J Cebra; Charles D Surh
Journal:  J Immunol       Date:  2005-03-15       Impact factor: 5.422

3.  Spontaneous and homeostatic proliferation of CD4 T cells are regulated by different mechanisms.

Authors:  Booki Min; Hidehiro Yamane; Jane Hu-Li; William E Paul
Journal:  J Immunol       Date:  2005-05-15       Impact factor: 5.422

4.  Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantation.

Authors:  Scott R Solomon; Stephan Mielke; Bipin N Savani; Aldemar Montero; Laura Wisch; Richard Childs; Nancy Hensel; John Schindler; Victor Ghetie; Susan F Leitman; Thao Mai; Charles S Carter; Roger Kurlander; Elizabeth J Read; Ellen S Vitetta; A John Barrett
Journal:  Blood       Date:  2005-04-07       Impact factor: 22.113

5.  Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen.

Authors:  M R Pelot; D A Pearson; K Swenson; G Zhao; J Sachs; Y G Yang; M Sykes
Journal:  Biol Blood Marrow Transplant       Date:  1999       Impact factor: 5.742

6.  Interleukin-7-dependent expansion and persistence of melanoma-specific T cells in lymphodepleted mice lead to tumor regression and editing.

Authors:  Li-Xin Wang; Rui Li; Guojun Yang; May Lim; Aisling O'Hara; Yiwei Chu; Bernard A Fox; Nicholas P Restifo; Walter J Urba; Hong-Ming Hu
Journal:  Cancer Res       Date:  2005-11-15       Impact factor: 12.701

7.  IL-15 but not IL-2 rapidly induces lethal xenogeneic graft-versus-host disease.

Authors:  Sameek Roychowdhury; Bradley W Blaser; Aharon G Freud; Kerry Katz; Darshna Bhatt; Amy K Ferketich; Valerie Bergdall; Donna Kusewitt; Robert A Baiocchi; Michael A Caligiuri
Journal:  Blood       Date:  2005-06-23       Impact factor: 22.113

8.  Prevention of graft versus host disease by inactivation of host antigen-presenting cells.

Authors:  W D Shlomchik; M S Couzens; C B Tang; J McNiff; M E Robert; J Liu; M J Shlomchik; S G Emerson
Journal:  Science       Date:  1999-07-16       Impact factor: 47.728

9.  Interleukin-15 enhances immune reconstitution after allogeneic bone marrow transplantation.

Authors:  Onder Alpdogan; Jeffrey M Eng; Stephanie J Muriglan; Lucy M Willis; Vanessa M Hubbard; Kartono H Tjoe; Theis H Terwey; Adam Kochman; Marcel R M van den Brink
Journal:  Blood       Date:  2004-07-27       Impact factor: 22.113

10.  Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells.

Authors:  Luca Gattinoni; Steven E Finkelstein; Christopher A Klebanoff; Paul A Antony; Douglas C Palmer; Paul J Spiess; Leroy N Hwang; Zhiya Yu; Claudia Wrzesinski; David M Heimann; Charles D Surh; Steven A Rosenberg; Nicholas P Restifo
Journal:  J Exp Med       Date:  2005-10-03       Impact factor: 14.307

View more
  8 in total

Review 1.  Induction of tolerance through mixed chimerism.

Authors:  David H Sachs; Tatsuo Kawai; Megan Sykes
Journal:  Cold Spring Harb Perspect Med       Date:  2014-01-01       Impact factor: 6.915

Review 2.  Innate allorecognition.

Authors:  Martin H Oberbarnscheidt; Fadi G Lakkis
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988

3.  Recommendations on Selection and Processing of RBC Components for Pediatric Patients From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative.

Authors:  Nicole D Zantek; Robert I Parker; Leo M van de Watering; Cassandra D Josephson; Scot T Bateman; Stacey L Valentine; Meghan Delaney
Journal:  Pediatr Crit Care Med       Date:  2018-09       Impact factor: 3.624

Review 4.  Immune tolerance in recipients of combined haploidentical bone marrow and kidney transplantation.

Authors:  M Sykes
Journal:  Bone Marrow Transplant       Date:  2015-06       Impact factor: 5.483

5.  Modeling Human Leukemia Immunotherapy in Humanized Mice.

Authors:  Jinxing Xia; Zheng Hu; Satoshi Yoshihara; Yuying Li; Chun-Hui Jin; Shulian Tan; Wei Li; Qingfeng Chen; Megan Sykes; Yong-Guang Yang
Journal:  EBioMedicine       Date:  2016-06-23       Impact factor: 8.143

6.  CTLA4-CD28 chimera gene modification of T cells enhances the therapeutic efficacy of donor lymphocyte infusion for hematological malignancy.

Authors:  Hyung Bae Park; Ji Eun Lee; Yu Mi Oh; Sang Jin Lee; Hyeon-Seok Eom; Kyungho Choi
Journal:  Exp Mol Med       Date:  2017-07-28       Impact factor: 8.718

Review 7.  Human Immune System Mice With Autologous Tumor for Modeling Cancer Immunotherapies.

Authors:  Liguang Sun; Chun-Hui Jin; Shulian Tan; Wentao Liu; Yong-Guang Yang
Journal:  Front Immunol       Date:  2020-10-08       Impact factor: 7.561

Review 8.  Cytokine Overproduction and Immune System Dysregulation in alloHSCT and COVID-19 Patients.

Authors:  Andrzej Lange; Janusz Lange; Emilia Jaskuła
Journal:  Front Immunol       Date:  2021-06-02       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.